Summit Securities Group’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-61
| Closed | -$4.74K | – | 720 |
|
|
2024
Q4 | $4.74K | Buy |
+61
| New | +$4.74K | ﹤0.01% | 398 |
|
|
2024
Q3 | – | Sell |
-53
| Closed | -$6K | – | 534 |
|
|
2024
Q2 | $6K | Buy |
+53
| New | +$6K | ﹤0.01% | 352 |
|
|
2024
Q1 | – | Sell |
-31
| Closed | -$4K | – | 426 |
|
|
2023
Q4 | $4K | Sell |
31
-13
| -30% | -$1.68K | ﹤0.01% | 376 |
|
|
2023
Q3 | $4K | Sell |
44
-87
| -66% | -$7.91K | ﹤0.01% | 321 |
|
|
2023
Q2 | $17K | Buy |
+131
| New | +$17K | ﹤0.01% | 542 |
|
|
2023
Q1 | – | Sell |
-1
| Closed | – | – | 758 |
|
|
2022
Q4 | $0 | Sell |
1
-1,541
| -100% | – | ﹤0.01% | 959 |
|
|
2022
Q3 | $124K | Buy |
+1,542
| New | +$124K | 0.01% | 325 |
|
|
2022
Q2 | – | Sell |
-1,760
| Closed | -$225K | – | 773 |
|
|
2022
Q1 | $225K | Buy |
+1,760
| New | +$225K | 0.03% | 216 |
|